Redeye is encouraged to learn that CLS’s TRANBERG Thermal Therapy System will be used by Focalyx Technologies, a developer of image-guided fusion target devices, to conduct a 20-patient, phase I clinical study.
ANNONS
Redeye is encouraged to learn that CLS’s TRANBERG Thermal Therapy System will be used by Focalyx Technologies, a developer of image-guided fusion target devices, to conduct a 20-patient, phase I clinical study.